perForm biologics Inc., Holliston, MA, United States of America.
Lawrence Ellison Center for Musculoskeletal Regeneration, Department of Orthopedic Surgery, School of Medicine, University of California at Davis, Sacramento, CA, United States of America.
Bone. 2020 Nov;140:115548. doi: 10.1016/j.bone.2020.115548. Epub 2020 Jul 27.
Bone morphogenetic proteins (BMPs) were purified from demineralized bone matrix by their ability to induce new bone formation in vivo. BMPs represent a large sub-family of proteins structurally related to TGF-beta and activins. Two BMP bone graft substitutes, BMP2 (InFuse®) and BMP7 (OP1®) have been developed as products for the repair of long bone non-union fractures and lumbar spinal fusion in humans. The approval of BMP2 and BMP7 based products for use in the clinic supports that the signals responsible for bone formation at ectopic sites can form a basis as therapeutics for bone repair and regeneration. This article describes a historical perspective of the discovery BMPs.
骨形态发生蛋白(BMPs)通过其在体内诱导新骨形成的能力从脱矿骨基质中被分离出来。BMPs 是 TGF-β和激活素的结构相关蛋白的大家族。两种 BMP 骨移植物替代品,BMP2(InFuse®)和 BMP7(OP1®)已被开发为用于修复长骨不愈合骨折和人类腰椎融合的产品。BMP2 和 BMP7 基于产品的临床应用的批准支持负责异位部位骨形成的信号可以作为骨修复和再生的治疗基础。本文描述了 BMPs 的发现的历史观点。